^
    No biomarker
    Testicular Cancer
    etoposide IV
    Sensitive: A1 - Approval
    No biomarker
    Testicular Cancer
    cisplatin
    Sensitive: A1 - Approval
    No biomarker
    Testicular Cancer
    ifosfamide
    Sensitive: A1 - Approval
    No biomarker
    Testicular Seminoma
    TI-CE
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Seminoma
    EP
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Seminoma
    VeIP
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Seminoma
    BEP
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Seminoma
    carboplatin
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Seminoma
    VIP
    Sensitive: A2 - Guideline
    TMB-H
    Testicular Seminoma
    TIP
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Cancer
    paclitaxel + gemcitabine
    Sensitive: A2 - Guideline
    MSI-H/dMMR
    Testicular Cancer
    cemiplimab
    Sensitive: A2 - Guideline
    TMB-H
    Testicular Cancer
    pembrolizumab
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Cancer
    etoposide oral
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Cancer
    GemOx
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Cancer
    TI-CE
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Cancer
    carboplatin + etoposide IV
    Sensitive: A2 - Guideline
    No biomarker
    Testicular Cancer
    GemPOx
    Sensitive: A2 - Guideline